It's only a matter of time when all the penny players are on $PHRRF with FDA approval, one of the only Ketamine pain meds with approval and will most likely replace all the compounding fake versions. Sales will be coming soon. This could have a nice valuation in 3-6 months.
Our CEO Frank Bedu-Addo, PhD, will participate in a fireside chat at the #virtual B. Riley Securities 4th Annual #Oncology Conference on Thursday, January 18, 2024, at 10:00 AM ET. https://t.co/xpnis4jUx2 $PDSB
$pavm $lucd. The link from my quote tweet about the PR from lucd seemed fishy so I found the info straight on lucd website. This seems like it’s a big deal -https://t.co/NDwIXgPqbx
As part of Oral, Head & Neck Cancer Awareness Month, we'd like to share a replay of our discussion featuring thought leaders in the field: https://t.co/pq2WY23X2m
#biotech#oncology#headandneckcancer#cancer#medicine
PDS Biotech Completes Successful Meeting with FDA for Triple Combination of PDS0101, PDS0301 and a Commercial Immune Checkpoint Inhibitor $PDSB https://t.co/F0gNasAkIU
@phillyrealty This MC is about as big of an opportunity as you could get with risk reward. AI is on a tear this year and people forgot veris is essentially an AI medical platform. Predictive algorithms for proactive treatment is the 💰